title: Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform.
abstract: The gene expression platform assay allows for robust and highly reproducible quantification of the expression of up to 800 transcripts (mRNA or miRNAs) in a single reaction. The miRNA assay counts transcripts by directly imaging and digitally counting miRNA molecules that are labeled with color-coded fluorescent barcoded probe sets (a reporter probe and a capture probe). Barcodes are hybridized directly to mature miRNAs that have been elongated by ligating a unique oligonucleotide tag (miRtag) to the 3' end. Reverse transcription and amplification of the transcripts are not required. Reporter probes contain a sequence of six color positions populated using a combination of four fluorescent colors. The four colors over six positions are used to construct a gene-specific color barcode sequence. Post-hybridization processing is automated on a robotic prep station. After hybridization, the excess probes are washed away, and the tripartite structures (capture probe-miRNA-reporter probe) are fixed to a streptavidin-coated slide via the biotin-labeled capture probe. Imaging and barcode counting is done using a digital analyzer. The immobilized barcoded miRNAs are visualized and imaged using a microscope and camera, and the unique barcodes are decoded and counted. Data quality control (QC), normalization, and analysis are facilitated by a custom-designed data processing and analysis software that accompanies the assay software. The assay demonstrates high linearity over a broad range of expression, as well as high sensitivity. Sample and assay preparation does not involve enzymatic reactions, reverse transcription, or amplification; has few steps; and is largely automated, reducing investigator effects and resulting in high consistency and technical reproducibility. Here, we describe the application of this technology to identifying circulating miRNA perturbations in irritable bowel syndrome.
authors.affiliation: Digestive Disorders Unit, National Institute of Nursing Research, National Institutes of Health, DHHS.
authors.forename: Nicolaas H
authors.initials: NH
authors.lastname: Fourie
authors.affiliation: Digestive Disorders Unit, National Institute of Nursing Research, National Institutes of Health, DHHS; National Institutes of Health Research Scholar, Howard Hughes Medical Institute.
authors.forename: Ralph M
authors.initials: RM
authors.lastname: Peace
authors.affiliation: Digestive Disorders Unit, National Institute of Nursing Research, National Institutes of Health, DHHS.
authors.forename: Sarah K
authors.initials: SK
authors.lastname: Abey
authors.affiliation: Digestive Disorders Unit, National Institute of Nursing Research, National Institutes of Health, DHHS.
authors.forename: LeeAnne B
authors.initials: LB
authors.lastname: Sherwin
authors.affiliation: Internal Medicine, Medical School, University of Michigan.
authors.forename: John W
authors.initials: JW
authors.lastname: Wiley
authors.affiliation: Digestive Disorders Unit, National Institute of Nursing Research, National Institutes of Health, DHHS; hendersw@mail.nih.gov.
authors.forename: Wendy A
authors.initials: WA
authors.lastname: Henderson
mesh_terms: D015342:DNA Probes; D015870:Gene Expression; D020869:Gene Expression Profiling; D017930:Genes, Reporter; D006801:Humans; D043183:Irritable Bowel Syndrome; D035683:MicroRNAs; D009693:Nucleic Acid Hybridization; D015203:Reproducibility of Results
chemical_list: D015342:DNA Probes; D035683:MicroRNAs